Author Interviews, Dermatology, Medical Imaging, Melanoma / 14.04.2025

MedicalResearch.com Interview with: [caption id="attachment_67909" align="alignleft" width="150"]Pau Rosés-Gibert, MDDermatology Department, Hospital Clínic Barcelona University of Barcelona, Fundació Clínic per la recerca biomédica, Institut d’Investigació Biomèdica August Pi i Sunyer, IDIBAPS Diagnosis Dermatologica, Dermavision Solutions Barcelona, Spain and Dermatology Department, Hospital de Figueres, Figueres, Spain Dr. Gibert[/caption] Pau Rosés-Gibert, MD Dermatology Department, Hospital Clínic Barcelona University of Barcelona, Fundació Clínic per la recerca biomédica, Institut d’Investigació Biomèdica August Pi i Sunyer, IDIBAPS Diagnosis Dermatologica, Dermavision Solutions Barcelona, Spain and Dermatology Department, Hospital de Figueres, Figueres, Spain MedicalResearch.com: What is the background for this study? Response: Skin cancer monitoring, particularly in high-risk patients with atypical mole syndrome, traditionally relies on total body photography (TBP) combined with digital dermoscopy. This approach, though effective, is slow, labor-intensive, and prone to oversight since clinicians must manually locate and image individual lesions. Recent improvements in automated imaging systems, lighting, and dermoscopy software have raised the potential for fully autonomous systems to streamline this process — leading to the development of the autonomous total body photographic and dermoscopic device tested in this study.